Sumatriptan Spray
Product Images NDC 45802-598

13 FDA label images from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 45802-598). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

Chemical-structure.jpg (Chemical Structure)
Chemical structure diagram of the active ingredient sumatriptan, showing its molecular connectivity and functional groups as part of the nasal spray formulation by Padagis Israel Pharmaceuticals Ltd.*
FDA Label Image

Figure-1.jpg (Figure 1)

Figure-1.jpg (Figure 1)
A line graph showing the estimated probability of response over time in minutes from initial dose. It compares response rates for placebo and sumatriptan at doses 5 mg, 10 mg, and 20 mg. The x-axis represents time from 0 to 120 minutes, and the y-axis represents probability percentage from 0% to 100%.*
FDA Label Image

Figure-2.jpg (Figure 2)

Figure-2.jpg (Figure 2)
A line chart showing the estimated probability of remediation or rescue over time in hours from the initial dose. The graph compares placebo and three different dosages (5 mg, 10 mg, and 20 mg), with probabilities increasing most rapidly after initial dosing and leveling off between 60% and 75% by 24 hours. The placebo curve shows the highest probability, followed by 5 mg, 10 mg, and 20 mg doses.*
FDA Label Image

Figure-a.jpg (Figure A)

Figure-a.jpg (Figure A)
An instructional illustration labeled as Figure A showing a person holding a small folded pamphlet or guide with one hand while unfolding it with the other, demonstrating how to open or read the enclosed information. The pamphlet appears related to the product but no text details are fully visible.*
FDA Label Image

Figure-b.jpg (Figure B)

Figure-b.jpg (Figure B)
An instructional illustration showing a woman using a nasal spray. The woman is holding a tissue to her nose, indicating the proper technique or action related to nasal spray use.*
FDA Label Image

Figure-c.jpg (Figure C)

Figure-c.jpg (Figure C)
An instructional line drawing showing a woman holding her finger near one nostril, demonstrating the nasal spray application technique for sumatriptan nasal spray.*
FDA Label Image

Figure-d.jpg (Figure D)

Figure-d.jpg (Figure D)
An instructional diagram showing a hand holding a nasal spray device for sumatriptan. Labels identify the nozzle and the plunger components of the spray applicator. The image is intended to demonstrate how to hold the spray for nasal administration.*
FDA Label Image

Figure-e.jpg (Figure E)

Figure-e.jpg (Figure E)
An instructional illustration showing a person administering a nasal spray, with one hand holding the spray device near the nostril and the other hand gently holding the opposite nostril closed. This image depicts the proper technique for using a nasal spray.*
FDA Label Image

Figure-f.jpg (Figure F)

Figure-f.jpg (Figure F)
An instructional line drawing labeled 'Figure F' showing a woman holding a nasal spray device near her nose, demonstrating how to position the spray for nasal administration of the medication.*
FDA Label Image

Carton (Image 01)

Carton (Image 01)
Packaging label for Sumatriptan Nasal Spray, USP 20 mg per 0.1 mL unit, for intranasal use only. The box contains 6 nasal spray units. Label includes product name, strength, dosage form, and manufacturer information (Perrigo). Storage and usage instructions, barcode, and NDC number 45802-598-06 are visible. The label states it is for prescription use only and provides inactive ingredient details.*
FDA Label Image

Serialization (Image 02)

Serialization (Image 02)
A label panel for SUMATRIPTAN nasal spray by Padagis Israel Pharmaceuticals Ltd featuring placeholder text fields for serial number, lot number, and expiration date. The label is designed to record batch and expiry information for sumatriptan nasal spray.*
FDA Label Image

Image 03

Image 03
Packaging label for Sumatriptan Nasal Spray, USP 5 mg, 0.1 mL per unit, in a box containing 6 nasal spray units. The label states it is for intranasal use only and specifies each unit dose contains 5 mg of sumatriptan. It is marked Rx only and manufactured by Perrigo, distributed by Padagis Israel Pharmaceuticals Ltd.*
FDA Label Image

Image 04

Image 04
A label for SUMATRIPTAN nasal spray by Padagis Israel Pharmaceuticals Ltd. The label includes placeholders for serial number (S/N), lot number, and expiration date, indicating where this product-specific information should be entered.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.